This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

IMARA Management

Management criteria checks 4/4

Key information

Rahul Ballal

Chief executive officer

US$2.0m

Total compensation

CEO salary percentage26.5%
CEO tenure4.7yrs
CEO ownership0.08%
Management average tenure3.8yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

Cancer drug developer Enliven Therapeutics and Imara to merge in all-stock deal

Oct 13

Imara: Potential Liquidation

Sep 29

We're Keeping An Eye On IMARA's (NASDAQ:IMRA) Cash Burn Rate

Jul 23
We're Keeping An Eye On IMARA's (NASDAQ:IMRA) Cash Burn Rate

We're Keeping An Eye On IMARA's (NASDAQ:IMRA) Cash Burn Rate

Sep 09
We're Keeping An Eye On IMARA's (NASDAQ:IMRA) Cash Burn Rate

IMARA (IMRA) EHA Investor Presentations - Slideshow

Jun 18

Is IMARA (NASDAQ:IMRA) In A Good Position To Invest In Growth?

May 03
Is IMARA (NASDAQ:IMRA) In A Good Position To Invest In Growth?

Companies Like IMARA (NASDAQ:IMRA) Are In A Position To Invest In Growth

Jan 11
Companies Like IMARA (NASDAQ:IMRA) Are In A Position To Invest In Growth

Imara's sickle cell treatment shows promising action in mid-stage study

Jan 06

Imara EPS in-line

Nov 05

CEO Compensation Analysis

How has Rahul Ballal's remuneration changed compared to IMARA's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022n/an/a

US$1m

Sep 30 2022n/an/a

-US$45m

Jun 30 2022n/an/a

-US$54m

Mar 31 2022n/an/a

-US$56m

Dec 31 2021US$2mUS$518k

-US$51m

Sep 30 2021n/an/a

-US$49m

Jun 30 2021n/an/a

-US$47m

Mar 31 2021n/an/a

-US$44m

Dec 31 2020US$626kUS$437k

-US$49m

Sep 30 2020n/an/a

-US$45m

Jun 30 2020n/an/a

-US$39m

Mar 31 2020n/an/a

-US$34m

Dec 31 2019US$2mUS$422k

-US$23m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$13m

Dec 31 2018US$938kUS$242k

-US$11m

Compensation vs Market: Rahul's total compensation ($USD1.95M) is about average for companies of similar size in the US market ($USD1.64M).

Compensation vs Earnings: Rahul's compensation has been consistent with company performance over the past year.


CEO

Rahul Ballal (44 yo)

4.7yrs

Tenure

US$1,951,029

Compensation

Dr. Rahul D. Ballal, Ph D., is the Chief Executive Officer of Imara Inc. June 13, 2018. Dr. Rahul serves as Director of Agios Pharmaceuticals, Inc. since August 2022.Dr. Ballal is President and Director a...


Leadership Team

NamePositionTenureCompensationOwnership
Rahul Ballal
President4.7yrsUS$1.95m0.084%
$ 140.0k
Michael Gray
CFO & COO3.8yrsUS$1.22m0.030%
$ 50.3k
Stephen Migausky
Senior VP of Legal & General Counsel2.8yrsno datano data

3.8yrs

Average Tenure

Experienced Management: IMRA's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Rahul Ballal
President4.7yrsUS$1.95m0.084%
$ 140.0k
Barbara Dalton
Independent Director7.1yrsUS$82.17k0%
$ 0
David Mott
Independent Chairman7.1yrsUS$120.59k0.87%
$ 1.4m
Carl Goldfischer
Independent Director7.1yrsUS$90.65k0%
$ 0
Joel Marcus
Board Observerno datano datano data
David Bonita
Independent Director3.9yrsUS$80.65k0%
$ 0
Mark Chin
Independent Director3.9yrsUS$85.68k0%
$ 0
Kim Andersen
Board Observer4.1yrsno datano data
Laura Williams
Independent Director1.7yrsUS$105.62k0%
$ 0
Edward Conner
Independent Director2.8yrsUS$79.65k0%
$ 0
Matthew Hammond
Board Observer4.1yrsno datano data
John Cassidy
Board Observer4.1yrsno datano data

4.1yrs

Average Tenure

53yo

Average Age

Experienced Board: IMRA's board of directors are considered experienced (4.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/02/24 17:24
End of Day Share Price 2023/02/23 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IMARA Inc. is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yigal NochomovitzCitigroup Inc
Edward WhiteH.C. Wainwright & Co.
Joseph SchwartzLeerink Partners LLC